Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients

An, Won Suk; Lee, S.M.; Son, Young Ki; Kim, S.E.; Kim, K.H.; Han, Jin Yeong; Bae, Hae-Rahn; Park, Yeonsang

doi:10.1016/j.plefa.2011.10.009

Cited by 29 publications

(21 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Stearic acid C18:0 concentration was found to be 13.53 in the erythrocyte membranes from the case group and 10.59 in that from the control group. Stearic acid concentration in this study was lower 19, 20, 22 24 as well as in agreement 26,27 to those reported in previous studies, and additionally, they were higher than that reported by Yilmaz et al 25 .…”

Section: Saturated Fatty Acidssupporting

confidence: 92%

“…The differences of oleic acid concentrations in between the groups were significant statistically p 0.05 Table 2 . Oleic acid concentrations reported in this study were in agreement 19,20,23,26 , as well as higher 22,24,27 and lower 25 than those reported in some previous studies. Linoleic acid C18:2 concentration was found to be 15.29 in the erythrocyte membranes in subjects of the case group and 15.39 in those of the control group.…”

Section: Unsaturated Fatty Acidssupporting

confidence: 92%

See 1 more Smart Citation

Erythrocyte Membrane Fatty Acid Composition in Premenopausal Patients with Iron Deficiency Anemia

et al. 2016

View full text Add to dashboard Cite

Section: Saturated Fatty Acidssupporting

confidence: 92%

Section: Unsaturated Fatty Acidssupporting

confidence: 92%

Erythrocyte Membrane Fatty Acid Composition in Premenopausal Patients with Iron Deficiency Anemia

et al. 2016

View full text Add to dashboard Cite

“…Therefore, decreasing erythrocyte total saturated fatty acid content may be helpful to reduce the incidence of CAD. The total saturated fatty acid content was decreased by ω -3 PUFAs supplementation in the general population and CKD patients [43–45]. …”

Section: Effects Of ω-3 Pufas On Erythrocyte Membrane Fatty Acid Cmentioning

confidence: 99%

“…Erythrocyte membrane oleic acid levels were significantly higher in patients with acute coronary syndrome compared with a control group [48, 49]. In a previous study, erythrocyte membrane oleic acid levels were also elevated in CKD patients, who are at higher risk for CVD, treated with dialysis [11, 43]. Furthermore, erythrocyte membrane oleic acid levels were associated with the vascular calcification score on plain radiographs, which was related to CVD and CAD in hemodialysis patients [50].…”

Section: Effects Of ω-3 Pufas On Erythrocyte Membrane Fatty Acid Cmentioning

confidence: 99%

“…Therefore, based on these results, erythrocyte membrane oleic acid levels may be related to CVD. ω -3 PUFAs supplementation decreased erythrocyte membrane oleic acid levels in CKD patients treated with dialysis [43, 44]. One study showed that a 30% reduction in arachidonic acid/EPA ratio was associated with a 70% reduction in the risk of myocardial infarction [31].…”

Section: Effects Of ω-3 Pufas On Erythrocyte Membrane Fatty Acid Cmentioning

confidence: 99%

See 1 more Smart Citation

Cardioprotective Effects ofω-3 PUFAs in Chronic Kidney Disease

Lee

2013

BioMed Research International

View full text Add to dashboard Cite

The prevalence rate of chronic kidney disease (CKD) is increasing worldwide, and cardiovascular disease (CVD) is a main cause of death in patients with CKD. The high incidence of CVD in CKD patients is related to chronic inflammation, dyslipidemia, malnutrition, atherosclerosis, and vascular calcification. Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) have been shown to reduce the risk of CVD. In this paper, we review the beneficial effects of ω-3 PUFAs on CVD and the possible cardioprotective mechanisms of ω-3 PUFAs in CKD patients by determining the effect of ω-3 PUFAs in the general population. ω-3 PUFAs have several cardioprotective benefits, such as reducing inflammation, decreasing oxidative stress, inhibiting platelet activity, exerting antiarrhythmic effects, and improving triglyceride levels, in the general population and patients with CKD. Modifications of erythrocyte membrane fatty acid content, including an increased ω-3 index and decreased oleic acid, after ω-3 PUFAs supplementation are important changes related to CVD risk reduction in the general population and patients with CKD. Further basic and clinical studies are essential to confirm the effects of ω-3 PUFAs on vitamin D activation, vascular calcification prevention, cardiovascular events, and mortality in CKD patients.

show abstract

Role of Omega-3 Fatty Acids in Cardiovascular Disorders

Peter

Jacob

2016

Omega-3 Fatty Acids

View full text Add to dashboard Cite

Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients

Cited by 29 publications

References 37 publications

Erythrocyte Membrane Fatty Acid Composition in Premenopausal Patients with Iron Deficiency Anemia

Erythrocyte Membrane Fatty Acid Composition in Premenopausal Patients with Iron Deficiency Anemia

Cardioprotective Effects ofω-3 PUFAs in Chronic Kidney Disease

Role of Omega-3 Fatty Acids in Cardiovascular Disorders

Contact Info

Product

Resources

About